- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SANTEN PHARMACEUTICAL CO LTD ADR Aktie jetzt für 0€ handeln | |||||
| 08.11.24 | Santen, Arctic Vision sign deal for ARVN001 to treat UME | 1 | Pharmaceutical Technology | ||
| 07.11.24 | Clearside Biomedical, Inc.: Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy ... | 288 | GlobeNewswire (Europe) | - Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China - - Agreement Provides Additional Validation for Clearside's Suprachoroidal Space... ► Artikel lesen | |
| 21.10.24 | NICE recommends Santen's Roclanda to treat glaucoma and ocular hypertension | 10 | PharmaTimes |
3 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVARTIS | 101,37 | -100,00 % | ROUNDUP/Aktien Europa Schluss: EuroStoxx gibt Vortagsgewinne ab | PARIS/LONDON/ZÜRICH (dpa-AFX) - Europas wichtigste Aktienmärkte haben am Mittwoch überwiegend schwach geschlossen. Die Gewinne des EuroStoxx 50 vom Vortag sind wieder ausradiert. Gegen diesen Trend... ► Artikel lesen | |
| MPH HEALTH CARE | 23,800 | 0,00 % | MPH Health Care Aktie: Finanzberichte neutral bewertet | Der Gesundheitsinvestor MPH Health Care AG verzeichnete am 21. Februar 2025 einen marginalen Kursrückgang von 0,43 Prozent auf 23,20 EUR. Die Aktie des Berliner Unternehmens zeigt sich dennoch in einer... ► Artikel lesen | |
| HIGH TIDE | 1,790 | -2,19 % | SNDL acquires minority stake in Canadian cannabis rival High Tide | ||
| PHARMASGP | 24,800 | 0,00 % | EQS-DD: PharmaSGP Holding SE: FUTRUE GmbH, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
25.11.2024 / 12:00... ► Artikel lesen | |
| COMPASS PATHWAYS | 2,800 | +7,69 % | Compass Pathways plc: Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression | Highlights: Screening closed for all sites and final participants being scheduled for dosing On track for top-line 6-week primary endpoint results in late Q2
Compass Pathways plc (Nasdaq:... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,820 | -1,36 % | Fosun Pharma Announces 2024 Annual Results | Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY
SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai... ► Artikel lesen | |
| SEELOS THERAPEUTICS | 2,000 | 0,00 % | Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc. ... | NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the Class A Ordinary Shares, unit, and warrant of Patria Latin American Opportunity Acquisition... ► Artikel lesen | |
| PROMINO NUTRITIONAL SCIENCES | 0,032 | -21,25 % | Promino Nutritional Sciences, Inc.: Promino Nutritional Sciences Inc. Announces Research Supporting Efficacy of Promino: One Serving is Equivalent to 75 Grams of Whey Protein in Stimulating Muscle Protein Synthesis | Burlington, Ontario--(Newsfile Corp. - March 3, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") announces today that it has established... ► Artikel lesen | |
| SAVARA | 2,720 | +3,82 % | Savara: Loan & Security Agreement Signed For Up To $200 Million With Hercules Capital | ||
| EVOLUS | 11,000 | -0,90 % | XFRA EVL: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ATYR PHARMA | 2,740 | +2,24 % | aTyr Pharma, Inc.: aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) ("aTyr" or "the Company"), a clinical stage biotechnology company engaged in the discovery and development of first-in-class... ► Artikel lesen | |
| EVOKE PHARMA | 3,840 | -100,00 % | Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-year Strong growth in key commercial metrics, including prescriber base, fill rates, and patient enrollments... ► Artikel lesen | |
| CIPHER PHARMACEUTICALS | 8,350 | 0,00 % | Cipher Pharmaceuticals upgraded to "Buy" at Leede Financial | ||
| IMMUNOPRECISE ANTIBODIES | 0,350 | +2,94 % | Benchmark maintains Speculative Buy on Immunoprecise stock | ||
| STEVANATO GROUP | 19,200 | 0,00 % | Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum | Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced... ► Artikel lesen |
SANTEN PHARMACEUTICAL CO LTD ADR gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 8,850 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SANTEN PHARMACEUTICAL CO LTD ADR finden Sie auf Wallstreet Online.
